We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+34.32%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.54B
AUM Growth
+$463M
Cap. Flow
+$4M
Cap. Flow %
0.16%
Top 10 Hldgs %
31.38%
Holding
255
New
23
Increased
59
Reduced
94
Closed
12

Top Buys

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$40.2M
2
EXAS
Exact Sciences
EXAS
+$37.4M
3
SYY icon
Sysco
SYY
+$30.8M
4
B
Barrick Mining
B
+$30.7M
5
ADI icon
Analog Devices
ADI
+$24.6M

Top Sells

Rank Stock Value
1
RVTY icon
Revvity
RVTY
+$30.9M
2
PRKS icon
United Parks & Resorts
PRKS
+$30M
3
WELL icon
Welltower
WELL
+$28.1M
4
HD icon
Home Depot
HD
+$24.7M
5
KKR icon
KKR & Co
KKR
+$23.8M

Sector Composition

Rank Sector Weight
1 Healthcare 22.4%
2 Technology 20.29%
3 Consumer Discretionary 11.24%
4 Financials 10.75%
5 Industrials 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ED icon
176
Consolidated Edison
ED
$41.3B
$472K 0.02%
6,568
+300
+5% +$23K
GDXJ icon
177
VanEck Junior Gold Miners ETF
GDXJ
$7.08B
$452K 0.02%
9,125
– –
AWH
178
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$450K 0.02%
+7,813
New +$522K
ORCL icon
179
Oracle
ORCL
$345B
$449K 0.02%
8,130
-300
-4% -$15.9K
IBM icon
180
IBM
IBM
$204B
$435K 0.02%
3,764
-941
-20% -$109K
EL icon
181
Estee Lauder
EL
$29.8B
$434K 0.02%
2,300
– –
GILD icon
182
Gilead Sciences
GILD
$164B
$421K 0.02%
5,475
– –
MO icon
183
Altria Group
MO
$122B
$415K 0.02%
10,565
-15,500
-59% -$605K
SYK icon
184
Stryker
SYK
$129B
$413K 0.02%
2,291
– –
FULC icon
185
Fulcrum Therapeutics
FULC
$250M
$410K 0.02%
22,400
– –
NVDA icon
186
NVIDIA
NVDA
$4.76T
$406K 0.02%
42,720
– –
EVBG
187
DELISTED
Everbridge, Inc. Common Stock
EVBG
$406K 0.02%
2,935
-100
-3% -$13K
ISRG icon
188
Intuitive Surgical
ISRG
$128B
$405K 0.02%
2,130
+150
+8% +$26.9K
TOL icon
189
Toll Brothers
TOL
$14.1B
$403K 0.02%
12,375
-19,025
-61% -$520K
WTRG icon
190
Essential Utilities
WTRG
$11.2B
$402K 0.02%
9,525
– –
PGC icon
191
Peapack-Gladstone Financial
PGC
$831M
$399K 0.02%
+21,299
New +$377K
CFR icon
192
Cullen/Frost Bankers
CFR
$10.3B
$394K 0.02%
5,270
– –
RITM icon
193
Rithm Capital
RITM
$5.16B
$385K 0.02%
51,800
-603,850
-92% -$3.91M
KMI icon
194
Kinder Morgan
KMI
$71.2B
$378K 0.01%
24,893
-1,451
-6% -$22.1K
STNG icon
195
Scorpio Tankers
STNG
$3.89B
$371K 0.01%
29,000
+10,600
+58% +$192K
ENBL
196
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$368K 0.01%
78,600
+9,800
+14% +$42K
SCHW
197
Charles Schwab
SCHW
$181B
$365K 0.01%
10,829
– –
CPAAU
198
DELISTED
Conyers Park II Acquisition Corp. Unit
CPAAU
$362K 0.01%
30,900
-5,900
-16% -$66.4K
WFC icon
199
Wells Fargo
WFC
$264B
$358K 0.01%
13,980
-12,986
-48% -$355K
AAAU icon
200
Goldman Sachs Physical Gold ETF Shares
AAAU
$2.47B
$356K 0.01%
+20,000
New +$342K
6 7
8
9 10

Similar funds

GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

Cannell & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Cannell & Co held 255 positions worth $2.54B, up 22% from $2.08B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Cannell & Co's Q2 2020 filing shows 23 new, 59 increased, 94 reduced and 12 closed positions. Its largest new stake was Exact Sciences: 467,933 shares worth $40.7M. The largest sale was Revvity, an estimated $30.9M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Cannell & Co's largest Q2 2020 buy was Exact Sciences: 467,933 shares worth $40.7M.
  • Cannell & Co added most to QuidelOrtho in Q2 2020, an estimated $40.2M increase.
  • Cannell & Co's biggest Q2 2020 reduction was Revvity, cutting an estimated $30.9M.
  • Cannell & Co fully exited KKR & Co in Q2 2020, selling an estimated $23.8M.
  • Cannell & Co's ten largest holdings make up 31% of its $2.54B portfolio in Q2 2020.
  • Cannell & Co opened 23 new positions and closed 12 in Q2 2020.
  • Cannell & Co's portfolio value rose 22% quarter-over-quarter to $2.54B.

Based on Cannell & Co's 13F filing for Q2 2020, filed 7 Aug 2020.